Cures Within Reach AI policy
Varies by programChecked November 9, 2026
In short
In its 2026 ReGRoW RFP, Cures Within Reach says it will not consider LOIs or full proposals substantially written, in whole or in part, by large language models or other generative AI. If significant AI use is detected, CWR may remove the application from funding consideration.
For applicants
- For the 2026 ReGRoW RFP, CWR will not consider LOI or full proposal applications substantially written, in whole or in part, by natural language processors, large language models, or other generative AI. If significant AI use is detected, CWR may remove an application from funding consideration.[1]
Sources
- [1]CWR ReGRoW RFP 2026
Cures Within Reach, February 16, 2026
“While CWR is very supportive of clinical trials that validate AI-driven drug-disease matches, CWR will not consider LOI or full proposal applications that are substantially written, either in whole or in part, by natural language processors, large language models or other generative AI technologies. If significant AI use is detected, CWR may remove an application from funding consideration.”
This page summarizes published guidance and is not legal advice. Policies change, and a specific solicitation can add its own rules, so confirm against the funding announcement before you apply. See every funder's AI policy.